MarketWise Q2 billings rose 57% to $91.2 million; FY 2026 billings target raised 10%
MarketWise reported second-quarter 2026 results, with billings up 57% year over year to $91.2 million while GAAP net revenue fell 5.2% to $75.8 million and the company posted a net loss of $2.6 million. The company raised its full-year 2026 billings target by 10% to $330 million and kept its $1.80 per share dividend target, but the company said GAAP net revenue is expected to decline in 2026 while billings rise.
Key points
- Q2 2026 billings were $91.2 million, up 57% from Q2 2025, the highest quarterly billings since 2023.
- Q2 2026 net revenue was $75.8 million, down 5.2% from $79.95 million a year earlier; net loss was $2.6 million, or $0.24 per share.
- FY 2026 billings target raised 10% to $330.0 million; cash from operating activities target of about $50 million was stated in the filing.
- Full-year 2026 dividend target of $1.80 per Class A share affirmed; Q2 dividends paid were $0.45 per share.
The filing
Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.